What is Proton Therapy

Call Now For More Information

General Questions or
Schedule an Appointment

1-855-528-7248

Current Patients

1-206-306-2800

Physician Line

1-888-987-7782

SCCA Proton Therapy Reps Attend Global Proton Meeting

SCCA Proton Therapy Reps Attend Global Proton Meeting

From May 22nd to 28th, six representatives from SCCA Proton Therapy Center attended the 55th Annual Meeting Particle Therapy Co-operative Group (PTCOG 55). Hosted at the Prague Congress Centre in the Czech Republic, the conference theme was “Particle Therapy: What Evidence is Necessary for a Clinical Standard?” PTCOG is a non-profit organization whose mission is to “promote science, technology and practical clinical application of particle therapy, with the ultimate goal of improving treatment of cancer to the highest possible standards in radiation therapy.” At the annual meetings, physicians, physicists and others can share their views on the role of particle therapy in the larger context, present findings from studies, and interpret new particle therapy data. It is also an opportunity to learn and network.

Medical representatives from around the world attended and shared abstracts, predominantly technical and clinical results that may lead to a turning point in the field of proton therapy.

Jing Zeng, MD, Assistant Professor at the Department of Radiation Oncology at the University of Washington, presented her findings from a recent clinical trial on esophageal cancer.

The study, titled “Proton Therapy Posterior Beam Approach with Pencil Beaming,” outlines the clinical outcome and feasibility of treatment for esophageal cancer. From February 2014 to June 2015, 13 patients with locally-advanced esophageal cancer were treated with proton therapy and surgery. The study showed that proton therapy with a single beam, pencil beam scanning technique for treatment of esophageal cancer appears safe and feasible, and offers dosimetric advantages over other beam arrangements. The biggest takeaway was that proton therapy minimized radiation dose to healthy organs, such as the heart and the lung.

For more information on the PTCOG 55, visit www.ptcog55.org.